Back to Search
ADINE BRANDES, MD
MD
Pediatrics Physician
NPI: 1578649901Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
1662291(NY)
Research & Publications (20)
Adaptive redistribution of NBCe1-A and NBCe1-B in rat kidney proximal tubule and striated ducts of salivary glands during acid-base disturbances.
PMID 17855492·Am J Physiol Regul Integr Comp Physiol·2007
7-preclinical
Serum elevation of CEA and CA 19-9 in an aggressive variant of prostatic carcinoma.
PMID 11859991·Acta Oncol·2001
5-case
Time- and dose-limiting erysipeloid rash confined to areas of lymphedema following treatment with gemcitabine--a report of three cases.
PMID 10757558·Anticancer Drugs·2000
5-case
Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status.
PMID 19514084·Cancer·2009
8-other
Pneumococcal capsular polysaccharide structure predicts serotype prevalence.
PMID 19521509·PLoS Pathog·2009
7-preclinical
Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951.
PMID 19224764·Neuro Oncol·2009
4-observational
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.
PMID 19269895·Lancet Oncol·2009
3-trial
Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: correlation With MGMT promoter methylation status.
PMID 19188675·J Clin Oncol·2009
8-other
Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.
PMID 19204207·J Clin Oncol·2009
3-trial
Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
PMID 19169684·Cancer Chemother Pharmacol·2009
3-trial
An expanded access program of erlotinib (Tarceva) in patients with advanced non-small cell lung cancer (NSCLC): data report from Italy.
PMID 18951651·Lung Cancer·2009
3-trial
Does bipolar pacemaker current activate blood platelets?
PMID 19422584·Pacing Clin Electrophysiol·2009
8-other
Treatment options for recurrent glioblastoma: pitfalls and future trends.
PMID 19445578·Expert Rev Anticancer Ther·2009
6-review
Adult neuroectodermal tumors of posterior fossa (medulloblastoma) and of supratentorial sites (stPNET).
PMID 19303318·Crit Rev Oncol Hematol·2009
6-review
The role of cetuximab in pre-treated refractory patients with metastatic colorectal cancer: outcome study in clinical practice.
PMID 18606595·J Chemother·2008
4-observational
Frequently asked questions in the medical management of high-grade glioma: a short guide with practical answers.
PMID 18790951·Ann Oncol·2008
8-other
Association between response to primary treatments and MGMT status in glioblastoma.
PMID 18983238·Expert Rev Anticancer Ther·2008
6-review
Phase II study of imatinib in patients with recurrent gliomas of various histologies: a European Organisation for Research and Treatment of Cancer Brain Tumor Group Study.
PMID 18824712·J Clin Oncol·2008
3-trial
[Long term electrocardiography (Holter monitoring)].
PMID 18956158·Herzschrittmacherther Elektrophysiol·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 51 E 25TH ST FL 3
NEW YORK, NY 10010 - Phone
- (212) 598-0331
Quick Facts
- NPI
- 1578649901
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile